ANNA LAHATTE: Open Payments
NPI 1225692320 · ATHENS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$929 in 24 payments from 9 companies in 2025. Trend: 2023 $619 · 2024 $770 · 2025 $929
Food & beverage: $929
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $250 |
| Boston Scientific Corporation | 2 | $232 |
| Abbott Laboratories | 1 | $123 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $107 |
| Amgen Inc. | 4 | $85 |
| Novartis Pharmaceuticals Corporation | 4 | $65 |
| CVRx, Inc. | 1 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| HEARTFLOW, INC. | 1 | $18 |
Products named: WAINUA, AVEIR, WATCHMAN FLX, Rhythmia Mapping System, LifeVest, REPATHA, LEQVIO, FARXIGA.
Industry payments across GA — which companies pay providers there.
